These findings suggest that upregulation of CXCL8 and its receptors, and other cytokine genes in CD16+ monocytes from severe COVID-19 amplify the inflammatory response of these cells, which may contribute to disease severity. This evidence concerns the gene CXCL8 and COVID-19.